Rare diseases
Investigational molecules
Locations
Back to Germany390 clinical trials in Erlangen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
GermanyCenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect
GermanyAZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
GermanyFrexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients
GermanyA study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease
GermanyA study to evaluate the safety and effectiveness of QEL-005 in patients with diffuse cutaneous systemic sclerosis and difficult to treat rheumatoid arthritis
GermanyMaintenance Therapy Study of Inavolisib with Pertuzumab and Trastuzumab in Patients with HER2‑Positive, PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer
GermanyA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
GermanyEffect of sodium hydrogen carbonate on kidney health in critically ill patients with metabolic acidosis and acute kidney injury
GermanyA study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
GermanyStudy of Lonapegsomatrin and Somatropin in Children and Adolescents with Short Stature or Growth Failure due to Turner Syndrome, SHOX Deficiency, SGA, or Idiopathic Short Stature
GermanyA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, including studies of new therapies for HR-positive and HER2-negative variants. Additional research encompasses lung cancer and various lymphomas.
Studies evaluate novel therapeutic combinations and targeted treatments for improved patient outcomes.
Comprehensive research into various autoimmune disorders, including lupus erythematosus, psoriasis, and systemic conditions. Studies focus on innovative therapeutic approaches.
Trials aim to develop more effective treatments for chronic autoimmune conditions.
Clinical investigations focusing on acute cerebral ischemic stroke and multiple system atrophy. Research emphasizes innovative therapeutic approaches for better patient outcomes.
Studies evaluate new therapeutic agents and treatment strategies for neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
